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Abstract
To assess the role of body adiposity index (BAI) in predicting cardiovascular disease (CVD) and coronary heart disease (CHD)
mortality, in comparison with body mass index (BMI), waist circumference (WC), and the waist circumference to hip
circumference ratio (WHR). This study was a prospective 15 year mortality follow-up of 4175 Australian males, free of heart
disease, diabetes and stroke. The Framingham Risk Scores (FRS) for CHD and CVD death were calculated at baseline for all
subjects. Multivariable logistic regression was used to assess the effects of the measures of obesity on CVD and CHD
mortality, before adjustment and after adjustment for FRS. The predictive ability of BAI, though present in the unadjusted
analyses, was generally not significant after adjustment for age and FRS for both CVD and CHD mortality. BMI behaved
similarly to BAI in that its predictive ability was generally not significant after adjustments. Both WC and WHR were
significant predictors of CVD and CHD mortality and remained significant after adjustment for covariates. BAI appeared to
be of potential interest as a measure of % body fat and of obesity, but was ineffective in predicting CVD and CHD.
Citation: Dhaliwal SS, Welborn TA, Goh LGH, Howat PA (2014) Obesity as Assessed by Body Adiposity Index and Multivariable Cardiovascular Disease Risk. PLoS
ONE 9(4): e94560. doi:10.1371/journal.pone.0094560
Editor: Noel Christopher Barengo, University of Tolima, Colombia
Received October 29, 2013; Accepted March 17, 2014; Published April 8, 2014
Copyright:  2014 Dhaliwal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was originally supported by a competitive grant from Healthway, the Western Australian Health Promotion Foundation. The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: S.Dhaliwal@curtin.edu.au
Introduction
There is a world-wide pandemic of obesity and its severe
consequences affect both developed and developing countries. The
body adiposity index (BAI) is proposed as a useful parameter to
assess obesity [1]. BAI is simple-to-use and it does not require the
assessment of body weight. Similar linear relationships between
BAI and percentage (%) body fat were observed in men and
women, thus suggesting that sex-specific adjustment of BAI to
estimate % body fat may not be required. It was developed on the
basis of showing a strong correlation with % body fat as assessed
using dual-energy x-ray absorptiometry (DXA) [1–7]. Both hip
circumference (HC) and height were strongly associated with %






BAI is promoted as a simple technique that does not require
scales and can be used in remote locations without equipment.
The body mass index (BMI (kg/m2) = weight/height2) remains
the international standard for assessing obesity in epidemiological
and clinical settings, even though there are recognised limitations
influencing its validity which include sex, ethnicity, frame size and
age [8–10]. BMI also does not differentiate between muscle mass
and fat mass [11]. Despite these limitations, the American Heart
Association recommends BMI to be used as a primary tool for
assessing body fatness because of its global acceptance and ease of
calculation.
While it is clear that controversy exists as to the best and most
simple measure to use to assess adiposity [12], comparative
outcome data is essential to resolve this debate. Studies have
assessed the association between BAI and health risks, however,
there is a need to further clarify the clinical utility of BAI in
assessing body adiposity and its association with diseases [2,3,6,13–
17]. In this regard, we had the opportunity to assess the role of
BAI in predicting cardiovascular disease (CVD) and coronary
heart disease (CHD) mortality in comparison with BMI and
measures of central obesity which includes waist circumference
(WC) and the waist circumference to hip circumference ratio
(WHR) in a population sample followed for 15 years.
Methods
Ethics statement
The Australian Institute of Health Interim Ethics Committee
provided ethical clearance for the 1989 third Risk Factor
Prevalence Survey, after consultation with the Commonwealth
Privacy Commissioner. Participation was entirely voluntary.
Participants signed an informed consent form to indicate their
willingness to participate in the survey [18]. The subsequent
linkage and analyses of the survey data with the National Death
Index were approved by the current Ethics Committee of the
Australian Institute of Health and Welfare.
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Study participants
The Australian third Risk Factor Prevalence Survey was
conducted in 1989 by the National Heart Foundation (NHF) to
provide a picture of the level of risk factors in the population of
registered voters living in Australian capital cities [18]. The city
catchment areas were Sydney (North and South), Melbourne,
Brisbane, Adelaide, Perth, Hobart, Darwin and Canberra. From
the initial age and sex stratified sample of 9279 Australian
residents, 4175 males who were free of heart disease, diabetes or
stroke at baseline were selected for this study. Respondents were
mainly of European descent.
Table 1. Characteristics of cohort without angina, diabetes or stroke at baseline.
CVD Deaths CHD Deaths Non-CVD Deaths Total Cohort
Count 88 64 258 4175
Age (years) 59.4 6 10.6 59.6 6 10.0 56.0 6 11.4 42.3 6 13.1
Current smoker (%) 35.2 40.6 36.4 27.9
Weight (kg) 81.2 6 14.0 81.2 6 11.8 77.9 6 12.4 79.2 6 12.3
Height (cm) 173.6 6 7.0 173.9 6 7.2 173.5 6 7.1 175.3 6 6.9
Waist circumference (cm) 96.7 6 10.5 96.7 6 9.6 92.3 6 11.4 89.9 6 10.4
Hip circumference (cm) 102.6 6 7.7 102.5 6 6.2 101.1 6 8.2 100.6 6 7.2
Body Mass Index (kg/m2) 26.8 6 4.0 26.8 6 3.4 25.9 6 3.7 25.8 6 3.5
Body Adiposity Index (%) 27.0 6 3.2 26.9 6 2.6 26.3 6 3.8 25.4 6 3.4
Waist to Hip ratio 0.94 6 0.06 0.94 6 0.06 0.91 6 0.07 0.89 6 0.06
Total cholesterol (mmol/L) 5.9 6 1.0 5.9 6 1.0 5.8 6 1.1 5.5 6 1.1
HDL cholesterol (mmol/L) 1.1 6 0.3 1.1 6 0.3 1.3 6 0.4 1.2 6 0.3
Total cholesterol to HDL ratio 5.5 6 1.7 5.7 6 1.8 5.0 6 1.7 4.9 6 1.6
Systolic Blood Pressure (mm Hg) 140.6 6 18.4 141.4 6 18.8 140.6 6 21.3 128.5 6 16.2
Diastolic Blood Pressure (mm Hg) 86.2 6 11.6 86.0 6 11.8 84.8 6 11.5 81.0 6 10.9
Framingham predicted risk - CVD death (%) 17.0 6 11.2 - 13.3 6 10.0 5.1 6 7.0
Framingham predicted risk - CHD death (%) - 13.0 6 8.0 9.7 6 7.2 3.7 6 5.5
Abbreviations: CVD, cardiovascular disease; CHD, coronary heart disease; HDL cholesterol, high density lipoprotein cholesterol.
doi:10.1371/journal.pone.0094560.t001
Table 2. Distribution* of cardiovascular disease (CVD) deaths and coronary heart disease (CHD) deaths by tertiles of obesity related
measures.
CVD Deaths CHD Deaths Non-CVD Deaths
Count 88 64 258
Body Adiposity Index (BAI) Low (%) 16.5 11.5 29.2
Medium (%) 32.9 37.7 27.2
High (%) 50.6 50.8 43.6
Body Mass Index (BMI) (kg/m2) Low (%) 22.6 16.7 32.9
Medium (%) 28.6 31.7 29.8
High (%) 48.8 51.7 37.3
Waist Circumference (WC) (cm) Low (%) 8.0 7.9 26.0
Medium (%) 33.3 31.7 30.2
High (%) 58.6 60.3 43.8
Hip Circumference (HC) (cm) Low (%) 23.0 17.5 34.5
Medium (%) 31.0 31.7 29.8
High (%) 46.0 50.8 35.7
Waist to Hip ratio (WHR) Low (%) 6.9 6.3 22.1
Medium (%) 26.4 25.4 32.9
High (%) 66.7 68.3 45.0
* Luw, medium and high refers to 1st, 2nd and 3rd tertiles, respectively.
Abbreviations: CVD, cardiovascular disease; CHD, coronary heart disease.
doi:10.1371/journal.pone.0094560.t002
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Risk factor measurements
At baseline, fasting serum lipid levels, systolic and diastolic
blood pressure, and smoking habits were recorded [19]. The
Framingham Risk Scores (FRS) for CHD and CVD death were
calculated at baseline for all 4175 males, using the equations from
Anderson’s paper [20]. The FRS were calculated from the
baseline data of subjects free of heart disease, diabetes or stroke,
after accounting for age, gender, systolic blood pressure, total
cholesterol, high density lipoprotein cholesterol and cigarette
smoking.
Physical measurements were made in light clothing and without
shoes. General obesity was assessed by BAI and BMI using
standardised methods [21]. BAI, which correlates well with %
body fat using DXA, was calculated with the formula [1]. Central
obesity was assessed by WC and WHR, using two observers by
standardised methods [21–23]. WC was measured from the front
at the narrowest point between the rib cage and the iliac crest after
full expiration and HC was assessed from the side at the maximal
extension of the buttocks using a metal tape, with no compression
of the skin. The mean was calculated from the measurements (to
the nearest centimetre) of the two observers. Height was measured
to the nearest centimetre and weight to the nearest 0.1 kilogram
(kg), with 1 kg deducted for light street clothing.
Cardiovascular disease outcomes
The data on these subjects were linked with the National Death
Index to determine the causes of death for 346 subjects who had
died by December 31, 2004. Of the 4175 males (age 42.3613.1
years), 88 died from CVD and 64 were from CHD. The causes of
death were coded according to the 10th revision of the
International Classification of Diseases (ICD-10): Codes I 00.0 to
I 99.0 for CVD deaths and codes I 20.0 to I 25.9 for CHD deaths
[24].
Statistical analysis
Spearman’s rank correlation was used to assess the association
between the measures of general and central obesity, and CVD
risk while accounting for fasting serum lipid levels, and systolic and
diastolic blood pressure. The data on the general and central
obesity variables were also divided into tertiles (low, medium and
high tertiles, respectively) for further analysis using regression
techniques. Multivariable logistic regression was used to assess the
effects of the measures of obesity on CVD and CHD mortality
using the 1989 NHF cohort, before adjustment (crude) and after
adjustment for FRS variables (age, systolic blood pressure, total
cholesterol, high density lipoprotein cholesterol and cigarette
smoking). The effects of obesity variables and FRS on CVD and
CHD mortality were expressed as odds-ratios and associated 95%
confidence intervals. P-values less than 0.05 were considered to be
statistically significant. Data was analysed using IBM SPSS
Statistics Version 19.
Results
The characteristics of the baseline cohort of 4175 males without
a history of angina, diabetes or stroke are presented in Table 1.
During the 15-year mortality follow-up, there were 346 deaths in
total, 88 deaths were due to CVD and 64 deaths were due to
CHD. Subjects who died from all-causes had higher obesity
measures, serum lipid and blood pressure levels, compared to the
total cohort. Those who experienced CVD and CHD deaths had
higher measures of general and central obesity, compared to those
who experienced non-CVD deaths. FRS was also higher in
subjects who died from CVD and CHD as compared to those who
experienced non-CVD deaths and the total cohort.
Table 2 presents the distribution of CVD deaths, CHD deaths
and non-CVD deaths across the tertiles of obesity related
measures, where low, medium and high represents the 1st, 2nd
and 3rd tertile, respectively. A trend towards a greater proportion
of deaths in the higher tertiles was evident in all obesity related
measures. There was, however, a steeper trend in WHR and WC
compared to BAI, BMI and HC, indicating a stronger association
for these measures between tertiles and deaths due to CVD and
CHD.
The associations between obesity related measures are present-
ed in Table 3. All correlations were significant (p,0.001) but
caution should be exercised in the interpretation of high
correlations, as computed variables may use other obesity related
measures in its calculations. The Spearman’s rank correlation
between BAI and BMI, WC and HC was higher compared to the
correlation with WHR. BMI was more highly correlated with BAI,
WC and HC compared to the correlation with WHR.
Table 4 presents the Spearman’s rank correlation between
obesity related measures and the continuous variables used in the
calculation of the FRS. Although all correlations were statistically
significant (p,0.001), BAI and BMI did not appear to correlate as
highly with the FRS variables as WC and WHR.
The results of the multivariable logistic regression used to assess
the effects of measures of obesity on CVD and CHD deaths are
Table 3. Spearman’s rank correlation between obesity
related measures.
Weight (kg) 1
Height (cm) 0.449 1
BMI (kg/m2) 0.833 20.068 1
Waist (cm) 0.800 0.109 0.842 1
Hip (cm) 0.866 0.294 0.794 0.807 1
WHR 0.476 20.092 0.603 0.830 0.373 1
BAI 0.398 20.500 0.766 0.629 0.632 0.415 1
Weight Height BMI Waist Hip WHR BAI
All correlations were significant (p-values , 0.001). Exercise caution in the
interpretation of correlation coefficients as computed variables may utilise
other variables in its calculation. Abbreviations: BMI, body mass index; waist,
waist circumference; hip, hip circumference; WHR, waist to hip ratio; BAI, body
adiposity index.
doi:10.1371/journal.pone.0094560.t003
Table 4. Spearman’s rank correlation between measures of
obesity and Framingham predictor variables.
BMI Waist WHR BAI
Systolic Blood Pressure 0.317 0.356 0.323 0.280
Diastolic Blood Pressure 0.361 0.391 0.342 0.297
Total Cholesterol 0.265 0.310 0.319 0.254
HDL Cholesterol 20.256 20.249 20.221 20.171
Triglycerides 0.390 0.433 0.427 0.315
Total Cholesterol to HDL ratio 0.383 0.404 0.386 0.301
All correlations were significant (p-values ,0.001).
Abbreviations: BMI, body mass index; waist, waist circumference; WHR, waist to
hip ratio; BAI, body adiposity index; HDL Cholesterol, high density lipoprotein
cholesterol.
doi:10.1371/journal.pone.0094560.t004
Body Adiposity Index and CVD Risk
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presented in Table 5 and Table 6, respectively. The effects of
BMI, WC, HC, WHR and BAI on CVD and CHD mortality were
first presented without adjustment (crude effects), then adjusted for
by age and finally adjusted for FRS variables (age, systolic blood
pressure, total cholesterol, high density lipoprotein cholesterol and
cigarette smoking). The predictive ability of BAI, though present
in the unadjusted analyses, was generally not significant after
adjustment for age and FRS for both CVD and CHD mortality.
BMI behaved similarly to BAI in that its predictive ability was
generally not significant after adjustments. Both WC and WHR
were significant predictors of CVD and CHD mortality and
remained significant after adjustment for covariates. The odds-
ratios for the comparison between the highest tertile and the lowest
tertile for CVD mortality was 3.84 (1.59–9.25) for WC and 5.42
(2.12–13.89) for WHR. In relation to CHD mortality, the odds-
ratios for the comparison between the highest tertile and the lowest




This study showed that BAI, like BMI, predicted CVD and
CHD mortality when unadjusted for age and cardiovascular risk
factors. But after adjustment for FRS variables (age, systolic blood
pressure, total cholesterol, high density lipoprotein cholesterol and
cigarette smoking), the association became non-significant. It is of
interest that BAI and BMI performed similarly. In this context, the
American Heart Association advises that BMI should be used with
another measure such as WC, as primary tools for assessing
adiposity. Individuals with elevated BMI or a proportionally high
WC for a given BMI should have other cardio-metabolic risk
factors evaluated for risk stratification. BAI requires a mathemat-
ical calculation of some complexity, and this cannot be used
conveniently in field studies. For all of these reasons, BAI cannot
be justified as a measure of any utility [25].
In contrast, this study showed that measures of central obesity
were clearly superior. Both WC and WHR predicted CVD and
Table 5. Odds-ratios and associated 95% confidence intervals for measures of obesity at baseline for cardiovascular disease (CVD)
mortality using multivariable logistic regression.
Unadjusted Adjusted by age Adjusted by FRS for CVD mortality
Body Adiposity Index (BAI)
FRS for CVD Mortality 3.02 (2.50–3.64) (p , 0.001)
Age 1.13 (1.10–1.16) (p , 0.001)
BAI tertiles:
Medium vs. Low 2.02 (1.06–3.85) (p = 0.033) 1.34 (0.69–2.61) (p = 0.381) 1.42 (0.72–2.82) (p = 0.316)
High vs. Low 3.14 (1.71–5.76) (p , 0.001) 1.32 (0.70–2.47) (p = 0.393) 1.50 (0.77–2.91) (p = 0.233)
Body Mass Index (BMI)
FRS for CVD mortality 3.08 (2.56–3.70) (p , 0.001)
Age 1.13 (1.10–1.16) (p , 0.001)
BMI tertiles:
Medium vs. Low 1.27 (0.69–2.33) (p = 0.443) 0.99 (0.53–1.85) (p = 0.979) 1.07 (0.57–2.03) (p = 0.829)
High vs. Low 2.19 (1.26–3.79) (p = 0.005) 1.47 (0.83–2.58) (p = 0.184) 1.35 (0.74–2.44) (p = 0.326)
Waist Circumference (WC)
FRS for CVD Mortality 2.83 (2.34–3.41) (p , 0.001)
Age 1.12 (1.10–1.15) (p , 0.001)
WC tertiles:
Medium vs. Low 4.38 (1.91–10.03) (p , 0.001) 2.46 (1.06–5.71) (p = 0.036) 3.28 (1.34–8.03) (p = 0.009)
High vs. Low 7.77 (3.51–17.18) (p , 0.001) 3.15 (1.40–7.07) (p = 0.005) 3.84 (1.59–9.25) (p = 0.003)
Hip Circumference (HC)
FRS for CVD Mortality 3.06 (2.56–3.67) (p , 0.001)
Age 1.13 (1.10–1.15) (p , 0.001)
HC tertiles:
Medium vs. Low 1.36 (0.76–2.43) (p = 0.303) 1.05 (0.58–1.91) (p = 0.872) 1.19 (0.64–2.21) (p = 0.575)
High vs. Low 2.15 (1.25–3.70) (p = 0.006) 1.40 (0.80–2.45) (p = 0.235) 1.44 (0.80–2.59) (p = 0.219)
Waist to Hip ratio (WHR)
FRS for CVD Mortality 2.75 (2.28–3.33) (p , 0.001)
Age 1.12 (1.09–1.15) (p , 0.001)
WHR tertiles:
Medium vs. Low 3.89 (1.58–9.57) (p = 0.003) 2.30 (0.92–5.73) (p = 0.074) 3.11 (1.16–8.33) (p = 0.024)
High vs. Low 10.06 (4.33–23.39) (p , 0.001) 3.82 (1.62–9.01) (p = 0.002) 5.42 (2.12–13.89) (p , 0.001)
Abbreviations: FRS, Framingham Risk Scores; CVD, cardiovascular disease.
doi:10.1371/journal.pone.0094560.t005
Body Adiposity Index and CVD Risk
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CHD mortality, but WHR showed the strongest risk ratios and
was independent of FRS. WHR is preferred because it is free of
ethnic bias whereas WC requires ethnic specific criteria [23,26].
Both WC and WHR are very simple techniques that can be
employed in remote locations without scales. We emphasise that
the measurement techniques, although simple, require careful
standardisation and quality control in terms of the sites of
measurement. WC should be measured at the narrowest level
between the ribs and hips after exhaling when viewed from the
front. HC should be measured from the point of maximum
buttock extent when viewed from the side. Two consecutive
placements would be recorded for each site and to the nearest 1
centimetre using a non-stretchable tape on a horizontal plane
without compression of the skin and the average value used. When
extreme obesity exists with abdominal apron, the HC can be
measured in supine position.
Comparison with other studies
Similar results were reported in other studies [10,11,27–29].
BMI, WC and weight were more consistently correlated with
cardiometabolic disease risk factors, compared to BAI, in a cohort
of 698 Mexican Americans [11]. Where significant correlations
were observed, BAI reported similar or weaker correlations with
cardiometabolic trait, compared to BMI [11]. A cross-sectional
study on Spanish Caucasian adult workers found that BAI was less
correlated with CVD and metabolic risk factors, compared to
BMI, WC and waist-to-height ratio (WHtR) [27]. WHtR reported
the best correlations [27]. In addition, BAI had lower discrimi-
natory capacity in diagnosing metabolic syndrome, compared to
BMI [27]. BAI was also less associated with CHD risk factors,
compared to BMI and WC, in another study among adults in the
1988–1994 National Health and Nutrition Examination Survey
(NHANES III) [29]. It was observed that BAI provided little
additional information on risk factor levels above those provided
by BMI [29]. Another cross-sectional study evaluating the
Table 6. Odds-ratios and associated 95% confidence intervals for measures of central obesity at baseline for coronary heart
disease (CHD) mortality using multivariable logistic regression.
Unadjusted Adjusted by age Adjusted by FRS for CHD mortality
Body Adiposity Index (BAI)
FRS for CHD Mortality 4.28 (3.21–5.69) (p , 0.001)
Age 1.13 (1.10–1.16) (p , 0.001)
BAI tertiles:
Medium vs. Low 3.32 (1.42–7.76) (p = 0.006) 2.23 (0.94–5.29) (p = 0.068) 2.17 (0.91–5.17) (p = 0.081)
High vs. Low 4.50 (1.98–10.26) (p , 0.001) 1.89 (0.82–4.39) (p = 0.137) 2.04 (0.87–4.80) (p = 0.103)
Body Mass Index (BMI)
FRS for CHD mortality 4.42 (3.33–5.87) (p , 0.001)
Age 1.13 (1.10–1.17) (p , 0.001)
BMI tertiles:
Medium vs. Low 1.91 (0.89–4.13) (p , 0.001) 1.52 (0.69–3.32) (p = 0.295) 1.55 (0.71–3.41) (p = 0.275)
High vs. Low 3.14 (1.54–6.44) (p = 0.002) 2.12 (1.02–4.40) (p = 0.043) 1.81 (0.86–3.83) (p = 0.118)
Waist Circumference (WC)
FRS for CHD Mortality 4.07 (3.05–5.43) (p , 0.001)
Age 1.12 (1.09–1.16) (p , 0.001)
WC tertiles:
Medium vs. Low 4.21 (1.57–11.24) (p = 0.004) 2.34 (0.86–6.32) (p = 0.094) 2.57 (0.94–6.98) (p = 0.065)
High vs. Low 8.04 (3.15–20.48) (p , 0.001) 3.22 (1.24–8.33) (p = 0.016) 3.16 (1.19–8.37) (p = 0.021)
Hip Circumference (HC)
FRS for CHD Mortality 4.42 (3.35–5.83) (p , 0.001)
Age 1.13 (1.10–1.16) (p , 0.001)
HC tertiles:
Medium vs. Low 1.83 (0.87–3.84) (p = 0.108) 1.43 (0.68–3.03) (p = 0.350) 1.51 (0.71–3.22) (p = 0.289)
High vs. Low 3.13 (1.57–6.24) (p = 0.001) 2.06 (1.02–4.15) (p = 0.044) 2.00 (0.98–4.09) (p = 0.057)
Waist to Hip ratio (WHR)
FRS for CHD Mortality 3.93 (2.93–5.25) (p , 0.001)
Age 1.12 (1.09–1.15) (p , 0.001)
WHR tertiles:
Medium vs. Low 4.04 (1.35–12.12) (p = 0.013) 2.37 (0.78–7.19) (p = 0.126) 2.62 (0.86–7.97) (p = 0.09)
High vs. Low 11.08 (3.97–30.94) (p , 0.001) 4.16 (1.47–11.78) (p = 0.007) 4.47 (1.55–12.89) (p = 0.006)
Abbreviations: FRS, Framingham Risk Scores; CHD, coronary heart disease.
doi:10.1371/journal.pone.0094560.t006
Body Adiposity Index and CVD Risk
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predictive ability of BAI, and % body fat and CVD risk factors in a
Chinese population found that BAI was not a better indicator of %
body fat, hypertension, dyslipidaemia, metabolic syndrome and
intima-media thickening of the common carotid arteries, com-
pared to BMI and WC [28]. These results were consistent with
another study which found that BAI was inferior to BMI in
predicting lipids, blood pressure and other CVD risk factors [16].
In summary, BAI does not overcome the limitations of BMI and is
possibly a poorer indicator of CVD risk than BMI [10,15,27,29].
Central obesity measures are better indicators of CVD risk
[12,15].
Support for WHR as the superior index of obesity for
cardiovascular risk assessment is seen in large cross-sectional
studies including the INTERHEART study [30] and the Obesity
in Asia collaboration study [23,31,32]. Similarly the Dallas Heart
Study demonstrated that WHR clearly outperforms WC and BMI
in estimating coronary calcium scores, although the cross-sectional
analysis could not identify WHR as an independent predictor
compared to conventional risk factors.
Strengths and limitations
This study provided evidence that BAI is inadequate for
assessing body adiposity and its association with CVD. Measures
of central obesity are better predictors of CVD compared to BAI
and BMI, in men. In addition, this study was carried out using a
representative sample of the Australian male population. Although
there is only one set of baseline measurements recorded for some
risk variables but variables including measures of obesity were
measured twice.
Conclusions
To conclude, BAI looked to be of potential interest and can be
used as a measure of % body fat and of obesity, but failed to show
any predictive ability for CVD and CHD deaths after age and risk
factor adjustments. Conversely, measures that include an assess-
ment of central obesity, particularly the WHR, shows strong
association with cardiovascular outcomes and this measure is also
quite simple to obtain in field studies and remote locations.
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8. Gallagher D, Visser M, Sepúlveda D, Pierson RN, Harris T, et al. (1996) How
Useful Is Body Mass Index for Comparison of Body Fatness across Age, Sex, and
Ethnic Groups? Am J Epidemiol 143: 228–239.
9. Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, et al. (2002) The
effect of sex, age and race on estimating percentage body fat from body mass
index: The Heritage Family Study. Int J Obes Relat Metab Disord 26: 789–796.
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